McKesson Corporation

McKesson Corporation

McKesson Corporation

Overview
Date Founded

1833

Headquarters

One Post Street, San Francisco, CA, 94104-5203, United States

Type of Company

Public

Employees (Worldwide)

78K

Industries

Wholesale: Consumer Non-Durables/Sundries
Hospitals & Patient Services
Medical Products & Equipment
IT Consulting & Services
Computer Software
Biotechnology

Company Description

McKesson is dedicated to delivering the vital medicines, medical supplies and information technologies that enable the health care industry to provide patients better, safer care. McKesson is made up of many businesses, all serving the health care industry. Our businesses fall into one of two primary categories: Distribution solutions. We are the largest pharmaceutical distributor in North America, distributing one-third of the medicines used every day. As one of the leading pharmaceutical companies, we supply more than 40,000 U.S. pharmacy locations, from Wal-Mart to the Department of Veterans Affairs to community pharmacies and hospitals. McKesson is also one of the leading medical supply companies and distributes medical-surgical supplies and homecare supplies. Healthcare Technology solutions. We develop and install healthcare information technology systems that eliminate the need for paper prescriptions and paper medical records. Our software and hardware are used in more than 70% of the nation's hospitals with more than 200 beds. Our hospital information system solutions include electronic health record system (EHR) and clinical decision support system such as Interqual. McKesson's Healthcare IT division also serves diverse areas within the health industry by offering solutions such as pharmacy automation and medical claims management software. McKesson publicly traded on NYSE under MCK Businesses Serving our customers—pharmacies, medical and pharmaceutical manufacturers, hospitals, and insurers—as the health care industry evolves is our primary goal. We have business lines to automate processes from medical supplies packaging to claims management, and revenue cycle management to medical imaging. McKesson's long history in pharmaceutical industry History McKesson has a long history in health care. We’ve been a trusted provider of medical supplies and goods for more than 175 years.

Contact Data
Trying to get in touch with decision makers at McKesson Corporation? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Chief Executive Officer

Chief Executive Officer & President

Executive Vice President & Chief Financial Officer

Executive Vice President, General Counsel & Chief Compliance Officer

Executive Vice President & Chief Human Resources Officer

Chief Accounting Officer, Senior Vice President & Controller

Senior Vice President & Treasurer

Executive Vice President & Chief Strategy & Business Development Officer

Executive Vice President, Chief Information Officer & Chief Technology Officer

Senior Vice President, Taxes

Board of Directors

Chief Executive Officer at McKesson Corporation

Former Chairman & Chief Executive Officer at Qwest Communications International, Inc.

Chief Executive Officer, President & Director at AMN Healthcare Services, Inc.

Senior Vice President, General Counsel & Corporate Secretary of the Company & of Medtronic, Inc at Medtronic Plc

President & Chief Executive Officer at Minute Maid Corp.

Founder at Yumanity Therapeutics, Inc.

Co-Chairman at U.S. Chamber of Commerce Foundation

Former Chief Financial Officer & Executive Vice President at Atlantic Richfield Co., Inc.

Director at McKesson Corporation

Paths to McKesson Corporation
Potential Connections via
Relationship Science
You
McKesson Corporation
Owners & Shareholders
Details Hidden

Boston Partners Global Investors has three divisions: Boston Partners, Weiss Peck & Greer Partners (WPG), and Redwood.Bostons' investment process is grounded in bottom-up fundamental analysis. The firm employs an efficient and repeatable investment process designed to identify companies with: attractive valuations, sound business fundamentals and improving business momentum. The firm's investment strategies include several long/short equity products which include selling securities short. The securities sold short may not be considered \"value\" securities but are considered to be overvalued by Boston Partners based on their quantitative screening and fundamental security analysis. For certain long/short portfolios, they use single name security swaps, negotiated on a bilateral basis and not cleared through a central clearing facility. Swaps are used to provide short exposure in markets where physical shorting is not allowed or to obtain exposure to a security to manage margin requirements more efficiently.WPG's Small-Cap Value investment approach employs proprietary fundamental research that seeks to identify undervalued companies in the least-covered areas of the small-cap market to achieve exceptional long-term returns. Boston Partners targets superior small-cap companies that are situated for positive change and are trading at attractive valuations. The investment team seeks to exploit market anomalies through both traditional value investments and special situations. WPG invests in a company when it possesses a near-term positive catalyst; its upside potential significantly outweighs its downside risk; and when it is selling at prices well below long-term valuation averages.The WPG Partners Micro Cap Opportunities Equity strategy seeks to add value through security selection as its primary source of outperformance. The strategy seeks to identify attractive micro cap stocks by applying a bottom-up, fundamental investment approach. Positions are primarily driven by the perceived underlying risk/reward relationship. Through its fundamental research, in most cases, sectors with strong catalysts, compelling valuations and the most favorable risk/reward characteristics are overweighed, while those with deteriorating industry fundamentals or those viewed as overvalued on an historical basis are underweighted;Redwood is an absolute return strategy that seeks to provide equity-like returns with substantially lower volatility than the broad market. The strategy is designed to achieve three specific investment goals: (1) provide equity like returns over a market cycle (2) provide those returns at approximately half the volatility of the broad market and (3) provide material downside protection.

Details Hidden

Vulcan Value Partners (VVP) seeks to achieve long-term capital appreciation by investing primarily in publicly-traded companies that are believed to be both undervalued and possessing a sustainable competitive advantage. The firm uses fundamental bottom-up analysis to identify companies believed to have sustainable competitive advantages allowing them to produce free cash flow and earn superior cash returns on capital. Vulcan seeks to invest in businesses that are run by ethical, capable, shareholder-oriented management teams that also are good operators and understand the importance of capital allocation. Vulcan then focuses their analysis on the difference between the price of the company's securities and their estimate of the intrinsic value of the securities. An investment becomes more attractive as the difference between value over price expands and the margin of safety increases. Vulcan generally invests larger amounts of a client's assets in companies determined to have lower price-to-value ratios and reduce capital committed to companies determined to have higher price-to-value ratios.

Details Hidden

Glenview Capital Management (GCM) manages the Glenview Funds, the Opportunity Funds, the GCM Equity Funds, and the Little Arbor Funds. The Glenview Funds employ a long/short strategy that invests in equity and fixed income securities using a bottom-up, fundamental research process. The Glenview Funds have position size and gross exposure guidelines. The Opportunity Funds employ a purely opportunistic investment approach, and have no limits as to the number or size of positions, security types or industry concentration. The GCM Equity Funds employ a long-only strategy that invests in the equity securities of companies with market-cap greater than $10 billion. The GCM Equity Funds are limited life funds that are being offered to existing investors and their affiliates in the Glenview Funds and the Opportunity Funds. The GCM Equity Funds have position size and exposure guidelines and do not expect to incur leverage in order to enhance investments. GCM also manages GCM Investment Partners LP, a private fund that is open to qualified employees of GCM and certain other persons. The Fund allocates its capital to individual funds in the Glenview Fund family and the Opportunity Fund family.^GCM's investment process focuses on deep, fundamental research and individual security selection primarily within equity and credit-oriented strategies. The firm employs a GARP investment approach that focuses on companies in stable industries, with recurring revenue streams or entrenched market positions. GCM may also focus on contrarian investments (cyclical or company specific). They often combine GARP and contrarian investing when a steady growth business emerges within a company as the dominant economic force over a more challenged business unit. GCM invests in stored or hidden value situations, where excess balance sheet capacity may be used to accelerate returns or where contractual rights or startup operations show no present value but may be significant drivers of value tomorrow. ^In addition to long equity investments, GCM commits significant capital to short equity positions. They look for companies whose industries face cyclical, transitory or secular headwinds, whose competitive position is likely to erode over the near- to medium-term, and companies whose liquidity profile will potentially create equity value impairment or cause future issuance of additional equity at lower prices. GCM may also maintain short positions in equity index futures or other index products to reduce net market risk. GCM also engages in long and short credit positions with emphasis on business or asset stability over growth. GCM may seek to reduce the risk through other hedges that protect the overall portfolio of the Funds, including interest rates, foreign currencies or sovereign, corporate or asset-backed credit spreads.

Recent Transactions
Details Hidden

McKesson Corporation purchases Medical Specialties Distributors LLC from New Mountain Capital LLC, North Sky Capital LLC

Details Hidden

McKesson Corporation purchases RxCrossroads LLC from CVS Health Corp.

Details Hidden

McKesson Corporation, McKesson Canada Corp. purchase Well.ca, Inc. from iNovia Capital, Inc., Extreme Venture Partners, Innovation Grade Ventures, Thunder Road Capital, Hedgewood, Inc.

Transaction Advisors
Accountant

Advised onMcKesson Corporation purchases HBO & Company

Legal Advisor

Advised onMcKesson Corporation purchases McQueary Bros. Drug Co.

Legal Advisor

Advised onMcKesson Corporation purchases HBO & Company

Legal Advisor

Advised onMcKesson Corporation purchases Medical Specialties Distributors LLC from New Mountain Capital LLC, North Sky Capital LLC

Legal Advisor

Advised onMcKesson Corporation purchases McKesson Medical-Surgical

Counsel

Advised onMcKesson Corporation purchases Medical Specialties Distributors LLC from New Mountain Capital LLC, North Sky Capital LLC

Advisors & Consultants
Advisor

Chief Financial Officer at Atlassian Corp. Plc

Legal Advisor

Partner at Morris, Manning & Martin LLP

Legal Advisor

Partner at Davis Wright Tremaine LLP

Clients

CVS Health Corp. engages in the provision of health care services. It operates trough the following segments: Pharmacy Services, Retail or Long Term Care, and Corporate. The Pharmacy Services segment offers pharmacy benefit management solutions. The Retail or Long Term Care segment includes selling of prescription drugs and assortment of general merchandise. The Corporate segment involves in providing management and administrative services. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.

To provide quality housing for low to moderate income residents of the community.

Rite Aid Corporation is one of the nation's leading drugstore chains with approximately 4,700 stores in 31 states and the District of Columbia, with a strong presence on both the East and West coasts, and 91,000 associates. Rite Aid is the largest drugstore chain on the East Coast and the third largest drugstore chain in the U.S. The company is publicly traded on the New York Stock Exchange under the ticker RAD.

Key Stats and Financials As of 2018
Market Capitalization
$24.8B
Total Enterprise Value
$36.4B
Earnings Per Share
$0.32
Revenue
$208B
EBITDAMargin
1.86%
Total Debt
$7.88B
Total Equity
$11.5B
EBITDA
$3.87B
Net Profit
$67M
Enterprise Value Sales
0.17x
Enterprise Value EBITDAOperating
9.39x
TEVNet Income
542.71x
Debt TEV
0.22x
Three Year Compounded Annual Growth Rate Of Revenue
5.18%
Five Year Compounded Annual Growth Rate Of Revenue
11.22%
Political Donations
$2,500
2014
$2,500
2014
$5,000
2014
Investments
Details Hidden

Predictive Health Technologies, Inc. provides healthcare technology services. The company was founded by Ralph D. Snyderman and Jason M. Langheier in 2004 and is headquartered in Durham, NC.

Details Hidden

MedVantx, Inc. provides medication access, adherence, and direct-to-patient consumer programs. It offers prescription assistance, patient engagement, anticipatory logistic solutions, and omni-channel platform. The company was founded Levin Scott Bechtler, Paul Cattaneo, and Robert J. Feeney Jr. in 2000 and is headquartered in San Diego, CA.

Details Hidden

RelayHealth Corp. provides online healthcare communication services. Its network is designed to streamline clinical, financial and administrative communication between patients, providers, payers, pharmacies, pharmaceutical manufacturers, and financial institutions. The firm works to accelerate the delivery of care and improve financial performance through solutions such as online consultation of physicians by patients, electronic prescribing, point-of-service pharmacy claims resolution by payers, pre-visit patient financial clearance by providers, and post-visit provider bill settlement by payers and patients. The company was founded by Assaf Morag, Niall Murphy, Ofir Baharav, Giovanni M. Colella, and Gary Gannot and is headquartered in Alpharetta, GA.

Investors
Details Hidden

Chairman & Chief Executive Officer at MBF Healthcare Partners LP

Suppliers
Aceto Corp. Medical Products & Equipment | Port Washington, NY

Aceto functions as a virtual manufacturing company, distributing more than 1,100 chemical compounds used principally as raw materials or finished products. With business operations in nine countries, Aceto’s global reach is distinctive in the industry, enabling the Company to source and supply quality products on a worldwide basis. Leveraging local professionals, Aceto sources more than two-thirds of its products from Asia, buying from approximately 500 companies in China and 200 in India.

Amgen, Inc. Biotechnology | Thousand Oaks, CA

Amgen, Inc. is a biotechnology medicines company, which discovers, develops, manufactures and markets medicines for grievous illnesses. The company focuses on human therapeutics and concentrates on innovating novel medicines based on advances in cellular and molecular biology. It markets recombinant protein therapeutics in supportive cancer care, nephrology and inflammation. The company's products include Neulasta, a pegylated protein, based on the Filgrastim molecule and NEUPOGEN, a recombinant-methionyl human granulocyte colony stimulating factor both of which selectively stimulate the production of neutrophils; Enbrel, an inhibitor of tumor necrosis factor, a substance that plays a role in the body's response to inflammatory diseases; Sensipar/Mimpara, a small molecule calcimimetic that lowers serum calcium levels; Vectibix, a monoclonal antibody that binds specifically to the epidermal growth factor receptor; and Nplate, a thrombopoietin receptor agonist that mimics endogenous TPO, the primary driver of platelet production. Amgen was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

Pfizer, Inc. Medical Support Services | New York, NY

Pfizer Inc. engages in the discovery, development, and manufacture of healthcare products specializes in medicines, vaccine, and consumer healthcare. It operates through the Pfizer Innovative Health (IH) and Pfizer Essential Health (EH) segments. The IH segment focuses on the development and commercializing medicines and vaccines for internal medicine, oncology, inflammation and immunology, rate disease, and consumer healthcare. The EH segment is involved in development and supply of branded generics, generic sterile injectable products, biosimilars, and select branded products including anti-infectives. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Awards & Honors
Rank #5
2016
Fortune Magazine - Fortune 1000 Companies
Sponsored by Fortune Magazine
Rank #5
2016
Fortune Magazine - Fortune 500 Companies
Sponsored by Fortune Magazine
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by McKesson Corporation. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of McKesson Corporation's profile does not indicate a business or promotional relationship of any kind between RelSci and McKesson Corporation.